Impact of recipient and donor pretransplantation body mass index on early postosperative complications after lung transplantation.
Body mass index
Donor acceptability criteria
Intensive care unit
Lung transplantation
Outcome
Primary graft dysfunction
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
03 Apr 2024
03 Apr 2024
Historique:
received:
16
01
2024
accepted:
20
03
2024
medline:
4
4
2024
pubmed:
4
4
2024
entrez:
3
4
2024
Statut:
epublish
Résumé
Prior studies have assessed the impact of the pretransplantation recipient body mass index (BMI) on patient outcomes after lung transplantation (LT), but they have not specifically addressed early postoperative complications. Moreover, the impact of donor BMI on these complications has not been evaluated. The first aim of this study was to assess complications during hospitalization in the ICU after LT according to donor and recipient pretransplantation BMI. All the recipients who underwent LT at Bichat Claude Bernard Hospital, Paris, between January 2016 and August 2022 were included in this observational retrospective monocentric study. Postoperative complications were analyzed according to recipient and donor BMIs. Univariate and multivariate analyses were also performed. The 90-day and one-year survival rates were studied. P < 0.05 was considered to indicate statistical significance. The Paris-North Hospitals Institutional Review Board approved the study. A total of 304 recipients were analyzed. Being underweight was observed in 41 (13%) recipients, a normal weight in 130 (43%) recipients, and being overweight/obese in 133 (44%) recipients. ECMO support during surgery was significantly more common in the overweight/obese group (p = 0.021), as were respiratory complications (primary graft dysfunction (PGD) (p = 0.006), grade 3 PDG (p = 0.018), neuroblocking agent administration (p = 0.008), prone positioning (p = 0.007)), and KDIGO 3 acute kidney injury (p = 0.036). However, pretransplantation overweight/obese status was not an independent risk factor for 90-day mortality. An overweight or obese donor was associated with a decreased PaO2/FiO2 ratio before organ donation (p < 0.001), without affecting morbidity or mortality after LT. Pretransplantation overweight/obesity in recipients is strongly associated with respiratory and renal complications during hospitalization in the ICU after LT.
Sections du résumé
BACKGROUND
BACKGROUND
Prior studies have assessed the impact of the pretransplantation recipient body mass index (BMI) on patient outcomes after lung transplantation (LT), but they have not specifically addressed early postoperative complications. Moreover, the impact of donor BMI on these complications has not been evaluated. The first aim of this study was to assess complications during hospitalization in the ICU after LT according to donor and recipient pretransplantation BMI.
METHODS
METHODS
All the recipients who underwent LT at Bichat Claude Bernard Hospital, Paris, between January 2016 and August 2022 were included in this observational retrospective monocentric study. Postoperative complications were analyzed according to recipient and donor BMIs. Univariate and multivariate analyses were also performed. The 90-day and one-year survival rates were studied. P < 0.05 was considered to indicate statistical significance. The Paris-North Hospitals Institutional Review Board approved the study.
RESULTS
RESULTS
A total of 304 recipients were analyzed. Being underweight was observed in 41 (13%) recipients, a normal weight in 130 (43%) recipients, and being overweight/obese in 133 (44%) recipients. ECMO support during surgery was significantly more common in the overweight/obese group (p = 0.021), as were respiratory complications (primary graft dysfunction (PGD) (p = 0.006), grade 3 PDG (p = 0.018), neuroblocking agent administration (p = 0.008), prone positioning (p = 0.007)), and KDIGO 3 acute kidney injury (p = 0.036). However, pretransplantation overweight/obese status was not an independent risk factor for 90-day mortality. An overweight or obese donor was associated with a decreased PaO2/FiO2 ratio before organ donation (p < 0.001), without affecting morbidity or mortality after LT.
CONCLUSION
CONCLUSIONS
Pretransplantation overweight/obesity in recipients is strongly associated with respiratory and renal complications during hospitalization in the ICU after LT.
Identifiants
pubmed: 38570744
doi: 10.1186/s12890-024-02977-z
pii: 10.1186/s12890-024-02977-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
161Informations de copyright
© 2024. The Author(s).
Références
WHO Consultation on Obesity (1999: Geneva S, Organization WH. Obesity : preventing and managing the global epidemic : report of a WHO consultation. World Health Organization; 2000. Available from: https://apps.who.int/iris/handle/10665/42330 . Cited 17 Feb 2023.
Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult lung transplantation report—2021; focus on recipient characteristics. J Heart Lung Transplant. 2021;40(10):1060–72.
doi: 10.1016/j.healun.2021.07.021
pubmed: 34446355
pmcid: 10285650
Lederer DJ, Wilt JS, D’Ovidio F, Bacchetta MD, Shah L, Ravichandran S, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med. 2009;180(9):887–95.
doi: 10.1164/rccm.200903-0425OC
pubmed: 19608717
pmcid: 2773915
Madill J, Gutierrez C, Grossman J, Allard J, Chan C, Hutcheon M, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90–day mortality following transplantation. J Heart Lung Transplant. 2001;20(3):288–96.
doi: 10.1016/S1053-2498(00)00315-6
pubmed: 11257554
Culver DA, Mazzone PJ, Khandwala F, Blazey HC, DeCamp MM, Chapman JT. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant. 2005;24(2):137–44.
doi: 10.1016/j.healun.2003.09.040
pubmed: 15701427
Kanasky WF, Anton SD, Rodrigue JR, Perri MG, Szwed T, Baz MA. Impact of body weight on long-term survival after lung transplantation. Chest. 2002;121(2):401–6.
doi: 10.1378/chest.121.2.401
pubmed: 11834649
González-Castro A, Llorca J, Suberviola B, Díaz-Regañón G, Ordóñez J, Miñambres E. Influence of nutritional status in lung transplant recipients. Transplant Proc. 2006;38(8):2539–40.
doi: 10.1016/j.transproceed.2006.08.084
pubmed: 17097994
Allen JG, Arnaoutakis GJ, Weiss ES, Merlo CA, Conte JV, Shah AS. The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant. 2010;29(9):1026–33.
doi: 10.1016/j.healun.2010.05.005
pubmed: 20558085
Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D’Ovidio F, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190(9):1012–21.
doi: 10.1164/rccm.201405-0973OC
pubmed: 25233138
pmcid: 4299586
Fernandez R, Safaeinili N, Kurihara C, Odell DD, Jain M, DeCamp MM, et al. Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score. J Thorac Cardiovasc Surg. 2018;155(4):1871–1879.e3.
doi: 10.1016/j.jtcvs.2017.11.031
pubmed: 29249487
Chaikriangkrai K, Jhun H, Graviss E, Jyothula S. Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation. Ann Thorac Med. 2015;10(3):169.
doi: 10.4103/1817-1737.160835
pubmed: 26229558
pmcid: 4518346
Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014–an update from the pulmonary transplantation council of the international society for heart and lung transplantation. J Heart Lung Transplant. 2015;34(1):1–15.
doi: 10.1016/j.healun.2014.06.014
pubmed: 25085497
Van Raemdonck D, Neyrinck A, Verleden GM, Dupont L, Coosemans W, Decaluwé H, et al. lung donor selection and management. Proc Am Thorac Soc. 2009;6(1):28–38.
doi: 10.1513/pats.200808-098GO
pubmed: 19131528
Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22(11):1183–200.
doi: 10.1016/S1053-2498(03)00096-2
pubmed: 14585380
Snell GI, Yusen RD, Weill D, Strueber M, Garrity E, Reed A, et al. Report of the ISHLT working group on primary lung graft dysfunction, part i: definition and grading—a 2016 consensus group statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2017;36(10):1097–103.
doi: 10.1016/j.healun.2017.07.021
pubmed: 28942784
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–184.
doi: 10.1159/000339789
pubmed: 22890468
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.
doi: 10.1001/jama.2016.0287
pubmed: 26903338
pmcid: 4968574
Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J heart lung transplant. 2007;26(12):1229–42.
doi: 10.1016/j.healun.2007.10.017
pubmed: 18096473
Atchade E, Barour S, Tran-Dinh A, Jean-Baptiste S, Tanaka S, Tashk P, et al. Acute kidney injury after lung transplantation: perioperative risk factors and outcome. Transplant Proc. 2020;52(3):967–76.
doi: 10.1016/j.transproceed.2020.01.018
pubmed: 32151389
Atchade E, Arsène A, Jean-Baptiste S, Tran Dinh A, Tanaka S, Stern J, et al. Donors brain-dead after successful resuscitation of cardiac arrest: Early outcome and postoperative complications of lung recipients. Resuscitation. 2023;184: 109720.
doi: 10.1016/j.resuscitation.2023.109720
pubmed: 36740093
Jomphe V, Lands LC, Mailhot G. Nutritional requirements of lung transplant recipients: challenges and considerations. Nutrients. 2018;10(6):790.
doi: 10.3390/nu10060790
pubmed: 29921799
pmcid: 6024852
Chambers DC, Cherikh WS, Harhay MO, Hayes D, Hsich E, Khush KK, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1042–55.
doi: 10.1016/j.healun.2019.08.001
pubmed: 31548030
pmcid: 6816340
Anderson MR, Cantu E, Shashaty M, Benvenuto L, Kalman L, Palmer SM, et al. Body mass index and cause-specific mortality after lung transplantation in the United States. Ann Am Thorac Soc. 2023;20(6):825–33.
doi: 10.1513/AnnalsATS.202207-613OC
pubmed: 36996331
Shah RJ, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, et al. Objective estimates improve risk stratification for primary graft dysfunction after lung transplantation. Am J Transplant. 2015;15(8):2188–96.
doi: 10.1111/ajt.13262
pubmed: 25877792
pmcid: 4721238
Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, Palmer SM, et al. Obesity and primary graft dysfunction after lung transplantation: the lung transplant outcomes group obesity study. Am J Respir Crit Care Med. 2011;184(9):1055–61.
doi: 10.1164/rccm.201104-0728OC
pubmed: 21799077
pmcid: 3208644
Whitson BA, Prekker ME, Herrington CS, Whelan TPM, Radosevich DM, Hertz MI, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26(10):1004–11.
doi: 10.1016/j.healun.2007.07.018
pubmed: 17919620
Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, Olthoff K, et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant. 2009;9(2):389–96.
doi: 10.1111/j.1600-6143.2008.02497.x
pubmed: 19120076
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–9.
doi: 10.1038/ijo.2010.5
Keller H, van der Schueren MAE, Consortium GLIM, Jensen GL, Barazzoni R, Compher C, et al. Global leadership initiative on malnutrition glim guidance on validation of the operational criteria for the diagnosis of protein‐energy malnutrition in adults. J Parenter Enter Nutr. 2020;44(6):992–1003.
doi: 10.1002/jpen.1806
National Cholesterol Education Program (NCEP) Expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the national cholesterol education program (NCEP) Expert panel on detection Evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
doi: 10.1161/circ.106.25.3143
Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 2008;34(2):183–4.
doi: 10.1016/j.diabet.2007.11.004
pubmed: 18329310